Share chart Novacyt S.A.
Extended chart
Simple chart
About Novacyt S.A.
Novacyt S.A., together with its subsidiaries, provides in vitro and molecular diagnostic tests for a range of infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, Lab21 Products, and IT-IS International segments. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. more details| Industry | Health Care Equipment & Supplies |
|---|---|
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | gbp |
| Сайт | https://www.novacyt.com |
| Цена ао | 0.538 |
| Change price per day: | 0% (0.538) |
|---|---|
| Change price per week: | 0% (0.538) |
| Change price per month: | 0% (0.538) |
| Change price per 3 month: | -16.07% (0.641) |
| Change price per half year: | -18.48% (0.66) |
| Change price per year: | +7.6% (0.5) |
| Change price per 3 year: | -72.69% (1.97) |
| Change price per 5 year: | -89.45% (5.1) |
| Change price per year to date: | -11.95% (0.611) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Legato Capital Management LLC | 13390 | 0.02 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Bryan Close | Chief Operations Officer | N/A | |
| Mr. Lyn Dafydd Rees | CEO & Executive Director | N/A | 1973 (52 years) |
| Mr. Steve Gibson | CFO & Director | N/A | |
| Dr. Joanne Mason | Chief Scientific Officer & Director | 1975 (50 years) | |
| Mr. David Franks | Chief Human Resources Officer | ||
| Paul Oladimeji | Group Head of R&D |
Address: United Kingdom, Eastleigh, York House - open in Google maps, open in Yandex maps
Website: https://www.novacyt.com
Website: https://www.novacyt.com
